Cai S - Search Results

1

Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

Cai S, Xie Y, Bagby TR, Cohen MS, Forrest ML. Cai S, et al. J Surg Res. 2008 Jun 15;147(2):247-52. doi: 10.1016/j.jss.2008.02.048. Epub 2008 Mar 26. J Surg Res. 2008. PMID: 18498877 Free PMC article.

2

Pharmacokinetics and disposition of a localized lymphatic polymeric hyaluronan conjugate of cisplatin in rodents.

Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Cai S, et al. J Pharm Sci. 2010 Jun;99(6):2664-71. doi: 10.1002/jps.22016. J Pharm Sci. 2010. PMID: 19960530 Free PMC article.

3

A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo.

Cohen MS, Cai S, Xie Y, Forrest ML. Cohen MS, et al. Among authors: cai s. Am J Surg. 2009 Dec;198(6):781-6. doi: 10.1016/j.amjsurg.2009.07.032. Am J Surg. 2009. PMID: 19969129 Free PMC article.

4

Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer.

Xie Y, Aillon KL, Cai S, Christian JM, Davies NM, Berkland CJ, Forrest ML. Xie Y, et al. Among authors: cai s. Int J Pharm. 2010 Jun 15;392(1-2):156-63. doi: 10.1016/j.ijpharm.2010.03.058. Epub 2010 Apr 2. Int J Pharm. 2010. PMID: 20363303 Free PMC article.

5

Localized doxorubicin chemotherapy with a biopolymeric nanocarrier improves survival and reduces toxicity in xenografts of human breast cancer.

Cai S, Thati S, Bagby TR, Diab HM, Davies NM, Cohen MS, Forrest ML. Cai S, et al. J Control Release. 2010 Sep 1;146(2):212-8. doi: 10.1016/j.jconrel.2010.04.006. Epub 2010 Apr 18. J Control Release. 2010. PMID: 20403395 Free PMC article.

6

Carrier-based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head & neck.

Cai S, Xie Y, Davies NM, Cohen MS, Forrest ML. Cai S, et al. Ther Deliv. 2010 Aug;1(2):237-45. doi: 10.4155/tde.10.38. Ther Deliv. 2010. PMID: 21339844 Free PMC article.

7

Lymphatic drug delivery using engineered liposomes and solid lipid nanoparticles.

Cai S, Yang Q, Bagby TR, Forrest ML. Cai S, et al. Adv Drug Deliv Rev. 2011 Sep 10;63(10-11):901-8. doi: 10.1016/j.addr.2011.05.017. Epub 2011 Jun 25. Adv Drug Deliv Rev. 2011. PMID: 21712055 Free PMC article. Review.

8

Subcutaneous delivery of nanoconjugated doxorubicin and cisplatin for locally advanced breast cancer demonstrates improved efficacy and decreased toxicity at lower doses than standard systemic combination therapy in vivo.

Cohen SM, Mukerji R, Cai S, Damjanov I, Forrest ML, Cohen MS. Cohen SM, et al. Among authors: cai s. Am J Surg. 2011 Dec;202(6):646-52; discussion 652-3. doi: 10.1016/j.amjsurg.2011.06.027. Epub 2011 Oct 8. Am J Surg. 2011. PMID: 21982998 Free PMC article.

9

Development of regional chemotherapies: feasibility, safety and efficacy in clinical use and preclinical studies.

Cai S, Bagby TR, Forrest ML. Cai S, et al. Ther Deliv. 2011 Nov;2(11):1467-84. doi: 10.4155/tde.11.112. Ther Deliv. 2011. PMID: 22229080 Free PMC article. Review.

10

Cellular uptake and internalization of hyaluronan-based doxorubicin and cisplatin conjugates.

Cai S, Alhowyan AA, Yang Q, Forrest WC, Shnayder Y, Forrest ML. Cai S, et al. J Drug Target. 2014 Aug;22(7):648-57. doi: 10.3109/1061186X.2014.921924. Epub 2014 Jun 3. J Drug Target. 2014. PMID: 24892741 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,547 results

Search Page